|9 Months Ended|
Sep. 30, 2018
|Subsequent Events [Abstract]|
13. Subsequent Events
On October 2, 2018, the Company held its 2018 Annual Meeting of Stockholders (the Annual Meeting). At the Annual Meeting, the Companys stockholders (i) elected the following four individuals as directors: Jeffrey Wolf, John Monahan, Ph.D., Edward B. Smith, III, and John Prendergast, Ph.D.; (ii) ratified and approved the appointment of BDO USA, LLP as the Companys independent registered public accounting firm for the year ending December 31, 2018; and (iii) approved and adopted the Companys 2018 Stock Incentive Plan, which allows the Company to grant up to 4,000,000 awards under the 2018 Stock Incentive Plan.
Effective October 31, 2018, the Company entered into an exchange agreement with the University of Miami pursuant to which the Company agreed to issue 35,000 shares of its common stock to the University of Miami in exchange for the return to the Company by the University of Miami of certain shares of capital stock it held in the Companys subsidiaries, Heat Biologics I, Inc. and Pelican Therapeutics, Inc.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef